SOX2 and head and neck squamous cell carcinoma: In an attempt to further confirm and validate our findings, the clinical relevance of NANOG and SOX2 mRNA expression was investigated by analyzing a cohort of 530 HNSCC patients from The Cancer Genome Atlas (TCGA) [24] using the platform cBioPortal (http://cbioportal.org/) [25].